Pancreatic polypeptide as target/marker of beta cell failure

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/68 (2006.01)

Patent

CA 2574442

The present invention relates to the monitoring of disease progression and diagnosis of beta-cell failure in diabetes by measuring levels of pancreatic hormone in a liquid sample, and to screening for novel compounds for the prevention and/or treatment of diabetes.

L'invention concerne le contrôle de la progression des maladies et le diagnostic d'une défaillance de cellules béta dans le diabète, par mesure des niveaux d'hormone pancréatique dans un échantillon liquide. L'invention concerne également le criblage de nouveaux composés pour la prévention et/ou le traitement du diabète.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pancreatic polypeptide as target/marker of beta cell failure does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pancreatic polypeptide as target/marker of beta cell failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pancreatic polypeptide as target/marker of beta cell failure will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1776412

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.